Dominari Holdings Inc. (BP2A.F)

1,9300 0,0000 (0,00 %) À la clôture : 08:00AM CEST

Dominari Holdings Inc.

725 5th Avenue
22nd Floor
New York, NY 10022
United States
212-393-4540
https://www.dominariholdings.com

Secteur(s): Healthcare
Secteur d’activité: Biotechnology
Employés à temps plein: 26

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Anthony C. Hayes Esq.	CEO & Chairman	927,04k	S.O.	1968
Mr. Kyle Michael Wool	President & Director	556,56k	S.O.	1978
Mr. George Michael Way CPA	Chief Financial Officer	S.O.	S.O.	1968
Mr. Christopher Devall	Chief Operating Officer	324,46k	S.O.	1983
Mr. Matthew B. McCullough	General Counsel	S.O.	S.O.	1986
Mr. Jaime Mercado Jr.	Chief Compliance Officer	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en EUR.

Description

Dominari Holdings Inc., through its subsidiaries, is engaged in wealth management, investment banking, sales and trading, and asset management. It operates through two segments: Dominari Financial and Legacy AIkido. It offers full-service brokerage services, including exchange-traded and over-the-counter corporate equity and debt securities, money market instruments, exchange-traded options, municipal bonds, mutual funds, exchange-traded funds, and unit investment trusts; financial and wealth planning services, such as asset management, individual and corporate retirement solutions, insurance and annuity products, IRAs and 401(k) plans, U.S. stock plan services, education savings programs, and trust and fiduciary services; and margin lending services. The company also provides financial advisory services to buyers and sellers on sales, divestitures, mergers, acquisitions, tender offers, privatizations, spin-offs, joint ventures, restructurings, and liability management; capital raising solutions through initial public offerings, follow-on offerings, confidentially marketed public offerings, registered directs, private investments in public equity, private placements, at-the-market offerings, and equity-linked offerings for corporate clients; institutional equity sales and trading; equity derivatives and index options; and trading in public and private debt securities, including investment and non-investment grade, distressed and convertible corporate securities. In addition, it offers asset management solutions, such as separately managed accounts, discretionary advisory accounts, non-discretionary advisory accounts, alternative investments, and private market platform. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Dominari Holdings Inc. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.